LTBR and neoplasm: Three weeks after inoculation, tumor weight analysis showed that no matter clodronate liposome treatment or knockout of LTBR in macrophages partially hindered tumor progression, but the combination strategy showed no additive effects, indicating the critical role of LTBR+ TAMs in LLC progression (Figure S8I–K).